日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Nation
Pharma firms start work on H1N1 vaccine
2009-Jul-7 11:03:08

China has announced that it would stockpile the H1N1 flu vaccine for 1 percent of the population by Oct 1, even as the 10 designated Chinese vaccine producers are getting busy with development and clinical trials.

The stockpile of 13 million injections will be used as a preventive measure to counter any sudden outbreak of the flu, Liang Wannian, deputy director of the Ministry of Health's contingency office, said.

He said the flu vaccine would be chiefly targeted at high-risk groups -- people with prevalent illnesses and pregnant women.

The first batch of China's H1N1 flu vaccine, developed by these 10 companies, is expected to be ready by the end of the month, and would undergo a two-month clinical trial before it is made available to the public, he said.

The 10 local vaccine makers include Beijing Sinovac Biotech Co Ltd, Zhuhai Hualan Biological Engineering Inc and Shenzhen Neptunus Interlong Bio-tech Co Ltd.

Sinovac announced recently that it had completed construction of the H1N1 virus seed bank necessary to produce a virus antigen.

The company received the seed virus from the US Center for Disease Control on June 8 and started producing the H1N1 vaccine the same day.

Sinovac said it expected to complete production of the first batch and initiate clinical trials of the vaccine by the end of this month. The flu vaccine has been named PANFLU.

The company got 100 million yuan on June 29 as loan from the Bank of Beijing, which will be used to purchase pharmaceutical raw material and for expanding its manufacturing facility, according to Sinovac Chairman, President and CEO Yin Weidong. The company's current annual vaccine production capacity is between 20 million and 30 million doses.

Shenzhen-listed Hualan Biological Engineering Inc said on July 1 that its equity holding subsidiary Hualan Biological Vaccine Co Ltd, a H1N1 vaccine developer, had borrowed 20 million yuan from each of the two shareholders of the parent company to fund its vaccine development effort.

Hualan can now manufacture nearly 200 million doses annually.

Li Yingpeng, a pharmaceutical analyst at Galaxy Securities, said 13 million doses of the H1N1 vaccine implied the vaccine makers could net a business of over 300 million yuan, as the average market price of other vaccines in China was around 30 yuan per dose.

"Though it seems these 10 companies have grabbed the huge business opportunities, they are, at the same time, shouldering high risks," Li said.

He said since the evolution of the H1N1 flu could not be predicted accurately, the returns on the huge investment required for development of the vaccine and clinical trials could not be guaranteed.

[Jump to ]
Nation | Biz | Comment | World | Celebrity | Odds | Sports | Travel | Health
ChinaDaily Mobile News
m.chinadaily.com.cn
To subscribe to China Daily, call 010-64918763 or email to circu@chinadaily.com.cn
主站蜘蛛池模板: 日韩视频在线观看一区二区 | 色网站入口 | www超碰| 九九国产视频 | 欧美日韩精品在线 | 欧美一区二区日韩 | 99热这里| 色资源在线观看 | 国产一区二区福利 | 色欧美日韩 | 98久久| 国产精品99精品久久免费 | 视频一区在线观看 | 天堂网国产 | 国产色中色 | 国产精品久久久久久久久久免费 | 国产亚洲精品精品精品 | 免费黄色在线 | 成人av在线看 | 欧美成人精品在线观看 | 中文字幕在线播出 | 国产一区不卡 | 中文字幕在线日韩 | 中文字幕永久在线视频 | 日本黄色视屏 | 久久黄视频 | 国产免费观看av | 日本黄在免 | 日韩精品在线免费视频 | 在线观看免费成人 | 中文字幕一区三区 | 激情高潮呻吟抽搐喷水 | 国产午夜手机精彩视频 | 免费一级片视频 | 激情欧美一区二区三区中文字幕 | 毛片视频免费观看 | 日本免费视频 | 亚洲啊啊啊啊啊 | 久久爱伊人 | 亚洲成人福利 | 久久精品5|